Clinical Trial Update: Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cilengitide in combination with radiochemotherapy for locally advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• cilengitide (cilengitide)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Locally Advanced Non Small Cell Lung Cancer (NSCLC) | Phase 1 | Status: COMPLETED